Aldometanib (LXY-05-029) is an orally active aldolase inhibitor. Aldometanib can activate lysosomal adenosine monophosphate-activated protein kinase ( AMPK ) and decreases blood glucose. Aldometanib can be used for the research of metabolic homeostasis.